New Key Statistics Module, Z-Score and F-Score
NAS:DCPH Key Ratios
| Market Cap $ M | 2,212.92 |
| Enterprise Value $ M | 1,965.42 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 6.65 |
| Price/Sales | 12.62 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 174.00 |
| EPS (TTM) $ | -2.21 |
| Beneish M-Score | -2.35 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 6.90 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -9.52 |
| EV-to-EBITDA | -9.61 |
| PEG | -- |
| Shares Outstanding M | 86.48 |
| Net Margin (%) | -108.87 |
| Operating Margin % | -118.09 |
| Pre-tax Margin (%) | -108.62 |
| Quick Ratio | 3.94 |
| Current Ratio | 4.19 |
| ROA % (ttm) | -38.85 |
| ROE % (ttm) | -50.29 |
| ROIC % (ttm) | -177.80 |
| Dividend Yield % | -- |
| Altman Z-Score | 7.45 |
DCPH Number of Guru Trades
DCPH Volume of Guru Trades
Gurus Latest Trades with NAS:DCPH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:DCPH is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Deciphera Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:DCPH
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers